*Deficient: Issuer Failed to Meet NASDAQ Continued Listing Requirements
Avenue Therapeutics to Host Virtual Key Opinion Leader (KOL) Event on April 4, 2024 GlobeNewswire
Market data is delayed by at least 15 minutes.
    Latest Story
    Avenue Therapeutics to Host Virtual Key Opinion Leader (KOL) Event on April 4, 2024
     GlobeNewswire
    Full Story →

    Headline News
    Avenue Therapeutics Reports Full Year 2023 Financial Results and Recent Corporate Highlights
    4:05p ET March 18 '24 GlobeNewswire
    Avenue Therapeutics Receives Positive Listing Determination from Nasdaq
    8:16a ET March 15 '24 GlobeNewswire
    Avenue Therapeutics to Present BAER-101 Preclinical Data at American Society for Experimental Neurotherapeutics (ASENT) 2024 Annual Meeting
    8:00a ET March 11 '24 GlobeNewswire
    More News →
    Day  3.34%Week  2.45%Month  2.70%More Charting →
    March 28 '24. Markets Closed.
    Last $0.15
    Day change   3.34%$0.01
    Open $0.1495
    Gap at open $0.00
    Previous close $0.15
    Trading volume 799,429
    10 Day avg vol. 1,202,977
    Shares out. 44.3Mil
    Market cap. $6.5Mil
    Trading activity Below Avg.
    Previous data from yesterday, March 27 '24.

    Historical Price Performance
    3 month   8.39% 
    6 month   79.14% 
    1 year   86.59% 
    2 year   98.09% 

    Earnings
    Previous 12m -$1.78
    Next 12m Estimate -$0.41
    P/E ratio 0.1x
    Revenue 0Mil

    Market data provided by News provided by